MedTech Dive May 24, 2022
Dive Brief:
- Dexcom is in talks to acquire Insulet in a deal that would combine two leaders of the diabetes technology market, Bloomberg reported Monday, citing unidentified people familiar with the matter. Spokespersons at Dexcom and Insulet declined to comment on the report when reached by MedTech Dive.
- The transaction would allow the combined company to offer both Dexcom’s continuous glucose monitors and Insulet’s insulin pumps at a time when the market is moving to an insulin delivery system that uses both devices. The companies currently have a partnership to integrate their devices, and the Food and Drug Administration has cleared devices that can work together.
- The deal could be completed in the coming weeks, according to the Bloomberg...
Today's Sponsors
Today's Sponsor